Compounds > etoposide
Page last updated: 2024-08-23

etoposide and Coronavirus Infections

etoposide has been researched along with Coronavirus Infections in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's7 (100.00)2.80

Authors

AuthorsStudies
Angelov, D; Cotter, AG; Fay, M; Lambert, JS; McGettrick, P; McGinty, T; O'Kelly, B; Sheehan, G1
Takami, A2
Aouidane, S; Belaaloui, G; Hamizi, K1
Loscocco, GG1
E, I; F, C; G, H; I, A; J, M; L, B; M, FR; M, LV; M, MB; M, U; P, D1
Fan, L; Li, JY; Miao, Y1

Other Studies

7 other study(ies) available for etoposide and Coronavirus Infections

ArticleYear
Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2.
    British journal of haematology, 2020, Volume: 190, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Betacoronavirus; Bleomycin; Coronavirus Infections; COVID-19; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Hydroxychloroquine; Idarubicin; Mediastinal Neoplasms; Pandemics; Pneumonia, Viral; Positron-Emission Tomography; Prednisone; Procarbazine; SARS-CoV-2; Treatment Outcome; Vinblastine; Vincristine

2020
Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19.
    International journal of hematology, 2020, Volume: 112, Issue:1

    Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Cytokines; Dose-Response Relationship, Drug; Etoposide; Humans; Lymphohistiocytosis, Hemophagocytic; Macrophages; Pandemics; Pneumonia, Viral; SARS-CoV-2; Topoisomerase II Inhibitors

2020
Etoposide-based therapy for severe forms of COVID-19.
    Medical hypotheses, 2020, Volume: 142

    Topics: Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Epstein-Barr Virus Infections; Etoposide; Humans; Influenza, Human; Lymphohistiocytosis, Hemophagocytic; Models, Theoretical; Pandemics; Pneumonia, Viral; Respiratory Distress Syndrome; SARS-CoV-2

2020
Reply to the letter by Gaetano Loscocco, Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19.
    International journal of hematology, 2020, Volume: 112, Issue:1

    Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Etoposide; Humans; Lymphohistiocytosis, Hemophagocytic; Macrophages; Pandemics; Pneumonia, Viral; SARS-CoV-2; Topoisomerase II Inhibitors

2020
Secondary hemophagocytic lymphohistiocytosis, HScore and COVID-19.
    International journal of hematology, 2020, Volume: 112, Issue:1

    Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Etoposide; Humans; Inflammation; Lymphocyte Activation; Lymphohistiocytosis, Hemophagocytic; Pandemics; Pneumonia, Viral; SARS-CoV-2; T-Lymphocytes, Cytotoxic; Topoisomerase II Inhibitors

2020
Etoposide treatment adjunctive to immunosuppressants for critically ill COVID-19 patients.
    The Journal of infection, 2020, Volume: 81, Issue:3

    Topics: Adult; Aged; Betacoronavirus; Coronavirus Infections; COVID-19; Critical Illness; Etoposide; Female; Humans; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Topoisomerase II Inhibitors

2020
Potential Treatments for COVID-19 Related Cytokine Storm - Beyond Corticosteroids.
    Frontiers in immunology, 2020, Volume: 11

    Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Cytokines; Etoposide; Humans; Immunomodulation; Interleukin-6; Lymphohistiocytosis, Hemophagocytic; Nitriles; Pandemics; Pneumonia, Viral; Pyrazoles; Pyrimidines; SARS-CoV-2

2020